These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18800451)

  • 1. Pharmacology of losartan, an angiotensin II receptor antagonist, in animal models of hypertension.
    Siegl PK; Kivlighn SD; Broten TP
    J Hypertens Suppl; 1995 Jul; 13(1):S15-21. PubMed ID: 18800451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Antihypertensive Therapies That Increase Expression of Cardioprotective Biomarkers Associated With the Renin-Angiotensin and Kallikrein-Kinin Systems.
    Lezama-Martinez D; Flores-Monroy J; Fonseca-Coronado S; Hernandez-Campos ME; Valencia-Hernandez I; Martinez-Aguilar L
    J Cardiovasc Pharmacol; 2018 Dec; 72(6):291-295. PubMed ID: 30422889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N; Sugano M; Otsuka S; Hata T
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress.
    Passaglia P; Ceron CS; Mecawi AS; Antunes-Rodrigues J; Coelho EB; Tirapelli CR
    Vascul Pharmacol; 2015 Nov; 74():49-59. PubMed ID: 25872164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of angiotensin II antagonists in human heart failure: function of the subtype 1 receptor.
    Regitz-Zagrosek V; Neuss M; Holzmeister J; Fleck E
    J Hypertens Suppl; 1995 Jul; 13(1):S63-71. PubMed ID: 18800459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
    Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
    J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D
    Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
    Jessup JA; Westwood BM; Chappell MC; Groban L
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):245-57. PubMed ID: 19531557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
    Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
    Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-week inhibition of the renin-angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks.
    Byars SG; Prestes PR; Suphapimol V; Takeuchi F; De Vries N; Maier MC; Melo M; Balding D; Samani N; Allen AM; Kato N; Wilkinson-Berka JL; Charchar F; Harrap SB
    Cardiovasc Res; 2024 May; 120(7):769-781. PubMed ID: 38501595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.